RCM
BIOS
Radcliffe Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-718,701
| Closed | -$7.79M | – | 465 |
|
|
2023
Q3 | $7.79M | Sell |
718,701
-46
| -0% | -$499 | 0.97% | 20 |
|
|
2023
Q2 | $7.65M | Buy |
718,747
+2,808
| +0.4% | +$29.9K | 0.65% | 30 |
|
|
2023
Q1 | $7.47M | Buy |
715,939
+160,584
| +29% | +$1.68M | 0.47% | 48 |
|
|
2022
Q4 | $5.7M | Buy |
555,355
+154,076
| +38% | +$1.58M | 0.18% | 168 |
|
|
2022
Q3 | $4.03M | Hold |
401,279
| – | – | 0.1% | 358 |
|
|
2022
Q2 | $4.02M | Buy |
401,279
+1,179
| +0.3% | +$11.8K | 0.09% | 361 |
|
|
2022
Q1 | $3.95M | Buy |
+400,100
| New | +$3.95M | 0.09% | 349 |
|